Taken together, our findings reveal that in prostate cancer cells, GALNT7 can modify the O-glycosylation of both cell surface proteins and proteins in the secretory pathway, leading to upregulation of the Tn antigen, which is a hallmark of cancer and involved in tumor progression and metastasis [38]. Here, GALNT7 is linked to prostate cancer.